1. Home
  2. TPST vs NBY Comparison

TPST vs NBY Comparison

Compare TPST & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TPST

Tempest Therapeutics Inc.

HOLD

Current Price

$2.03

Market Cap

30.9M

Sector

Health Care

ML Signal

HOLD

Logo NovaBay Pharmaceuticals Inc.

NBY

NovaBay Pharmaceuticals Inc.

HOLD

Current Price

$1.95

Market Cap

31.6M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
TPST
NBY
Founded
2011
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.9M
31.6M
IPO Year
2012
2007

Fundamental Metrics

Financial Performance
Metric
TPST
NBY
Price
$2.03
$1.95
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$11.00
N/A
AVG Volume (30 Days)
278.7K
608.2K
Earning Date
05-08-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
35.42
EPS
N/A
0.76
Revenue
$295,000.00
$370,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$2.57
Revenue Growth
N/A
N/A
52 Week Low
$1.50
$0.43
52 Week High
$12.22
$19.95

Technical Indicators

Market Signals
Indicator
TPST
NBY
Relative Strength Index (RSI) 52.45 57.82
Support Level $1.57 $1.01
Resistance Level $2.48 $2.52
Average True Range (ATR) 0.14 0.26
MACD 0.03 0.11
Stochastic Oscillator 67.59 96.45

Price Performance

Historical Comparison
TPST
NBY

About TPST Tempest Therapeutics Inc.

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

Share on Social Networks: